We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
+1.33%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$1.15B
AUM Growth
-$24.6M
Cap. Flow
-$207M
Cap. Flow %
-17.99%
Top 10 Hldgs %
47.81%
Holding
236
New
24
Increased
50
Reduced
114
Closed
26

Sector Composition

1 Financials 5.27%
2 Technology 3.23%
3 Communication Services 2.48%
4 Healthcare 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHM icon
26
Schwab US Mid-Cap ETF
SCHM
$14.6B
$9.87M 0.86%
614,607
-109,005
-15% -$1.73M
SCHP icon
27
Schwab US TIPS ETF
SCHP
$16.5B
$9.71M 0.84%
352,830
-26,610
-7% -$738K
CINF icon
28
Cincinnati Financial
CINF
$28B
$8.93M 0.78%
123,217
-10,533
-8% -$747K
IWD icon
29
iShares Russell 1000 Value ETF
IWD
$81.9B
$8.9M 0.77%
76,446
+11,736
+18% +$1.35M
IEFA icon
30
iShares Core MSCI EAFE ETF
IEFA
$186B
$8.88M 0.77%
145,869
+50,651
+53% +$3.06M
EEM icon
31
iShares MSCI Emerging Markets ETF
EEM
$28B
$8.68M 0.75%
209,671
-172,927
-45% -$7.04M
VWO icon
32
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$8.49M 0.74%
207,961
+13,849
+7% +$561K
EFA icon
33
iShares MSCI EAFE ETF
EFA
$76.5B
$8.18M 0.71%
125,508
-342,659
-73% -$22.2M
PG icon
34
Procter & Gamble
PG
$349B
$6.86M 0.6%
78,707
+26,965
+52% +$2.38M
JNJ icon
35
Johnson & Johnson
JNJ
$609B
$6.75M 0.59%
51,035
-2,658
-5% -$339K
RY icon
36
Royal Bank of Canada
RY
$299B
$5.84M 0.51%
+80,500
New +$5.64M
VCIT icon
37
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.7B
$5.68M 0.49%
64,933
-1,043
-2% -$91.1K
GOOGL icon
38
Alphabet (Google) Class A
GOOGL
$4.23T
$5.5M 0.48%
118,280
-10,560
-8% -$494K
USB icon
39
US Bancorp
USB
$98.4B
$5.48M 0.48%
105,628
+28,649
+37% +$1.48M
JPM icon
40
JPMorgan Chase
JPM
$907B
$5.16M 0.45%
56,423
-3,897
-6% -$336K
SCHZ icon
41
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
$5.01M 0.44%
191,696
+1,554
+0.8% +$40.5K
BSV icon
42
Vanguard Short-Term Bond ETF
BSV
$44.7B
$4.62M 0.4%
57,893
+17,143
+42% +$1.37M
PEP icon
43
PepsiCo
PEP
$187B
$4.61M 0.4%
39,942
+577
+1% +$66.2K
WFC icon
44
Wells Fargo
WFC
$265B
$4.33M 0.38%
78,224
+9,499
+14% +$509K
IWR icon
45
iShares Russell Mid-Cap ETF
IWR
$56.6B
$4.32M 0.38%
90,012
-3,040
-3% -$144K
CVX icon
46
Chevron
CVX
$373B
$4.3M 0.37%
41,210
+5,482
+15% +$581K
AMU
47
DELISTED
ETRACS Alerian MLP Index ETN
AMU
$4.05M 0.35%
216,026
+37,713
+21% +$730K
IWV icon
48
iShares Russell 3000 ETF
IWV
$19.6B
$3.93M 0.34%
27,278
-564
-2% -$80.2K
IFGL icon
49
iShares International Developed Real Estate ETF
IFGL
$82M
$3.87M 0.34%
135,954
-25,273
-16% -$723K
DIS icon
50
Walt Disney
DIS
$170B
$3.61M 0.31%
33,960
-1,038
-3% -$114K

Similar funds

Aspiriant LLC's Q2 2017 Portfolio in Review

As of Q2 2017, Aspiriant LLC held 236 positions worth $1.15B, down 2.1% from $1.17B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Aspiriant LLC withdrew a net $207M in Q2 2017, closing 26 positions and reducing 114 holdings. Its most notable exit was iShares Core High Dividend ETF, an estimated $5.52M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5.3% of assets, up from 4.6% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Aspiriant LLC opened a new position in Royal Bank of Canada worth $5.84M.

  • Aspiriant LLC's largest Q2 2017 buy was Royal Bank of Canada: 80,500 shares worth $5.84M.
  • Aspiriant LLC added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $10.1M increase.
  • Aspiriant LLC's biggest Q2 2017 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $94.5M.
  • Aspiriant LLC fully exited iShares Core High Dividend ETF in Q2 2017, selling an estimated $5.52M.
  • Aspiriant LLC's ten largest holdings make up 48% of its $1.15B portfolio in Q2 2017.
  • Aspiriant LLC opened 24 new positions and closed 26 in Q2 2017.
  • Aspiriant LLC's portfolio value fell 2.1% quarter-over-quarter to $1.15B.

Based on Aspiriant LLC's 13F filing for Q2 2017, filed 3 Aug 2017.